MediPharm Labs Corp. (TSE:LABS – Get Free Report)’s share price was up 5.9% on Wednesday . The stock traded as high as C$0.10 and last traded at C$0.09. Approximately 478,567 shares changed hands during trading, an increase of 99% from the average daily volume of 241,019 shares. The stock had previously closed at C$0.09.
MediPharm Labs Trading Up 12.5%
The firm has a market capitalization of C$38.24 million, a price-to-earnings ratio of -4.50 and a beta of -0.45. The company has a fifty day moving average price of C$0.07 and a two-hundred day moving average price of C$0.07. The company has a current ratio of 2.77, a quick ratio of 3.10 and a debt-to-equity ratio of 0.56.
About MediPharm Labs
Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API), and advanced derivative products produced in a GMP-certified facility with ISO-standard clean rooms. MediPharm has invested in an expert research-driven team, state-of-the-art technology, advanced purification methodologies, and purpose-built facilities to deliver pure, trusted, precision-dosed cannabinoid products for domestic and international markets.
Further Reading
- Five stocks we like better than MediPharm Labs
- Qualcomm Stock Doubles: New Era? Or Another False Start?
- 3 Industrial Stocks That Just Crushed Earnings
- A Quantum Shift: Why Speculative Money Is Ditching AI
- Reading the Stripes: Is The Industrial Recession Over?
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
